Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-27

Clinical Trial Update: Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether belatacept affects the pharmacokinetics of an Inje Cocktail in healthy volunteers; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inje Cocktail
  • belatacept (belatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Transplant Rejection | Phase 4 | Status: COMPLETED | Results posted: 2014-06-27